Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency

Current therapeutic approaches to the treatment of endocrine ophthalmopathy (EOP) are based on nonspecific immunosuppression with glucocorticosteroids (GCs) and radiation therapy of the eye orbits. However, some patients exhibit resistance to the treatment. In a previous study, we have detected high...

ver descrição completa

Detalhes bibliográficos

Principais autores:	N. Yu. Sviridenko, E. G. Bessmertnaya, I. M. Belovalova, M. S. Sheremeta, D. M. Babaeva, N. M. Malysheva, E. A. Troshina, G. A. Melnichenko
Formato:	Artigo
Idioma:	Russo
Publicado em:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-11-01
Colecção:	Медицинская иммунология
Assuntos:	graves’ disease endocrine ophthalmopathy cytokines antibodies glucocorticoids
Acesso em linha:	https://www.mimmun.ru/mimmun/article/view/2514
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!